Autonomix announces reverse stock split

The woodlands, tx, oct. 22, 2024 (globe newswire) -- autonomix medical, inc. (nasdaq: amix) (“autonomix” or the “company”), a medical device company focused on advancing precision nerve-targeted treatments, today announced that it filed an amendment to its amended and restated certificate of incorporation with the secretary of state of the state of delaware to effect a 1-for-20 reverse stock split of its common stock. the reverse stock split will take effect at 11:59 pm (eastern time) on october 24, 2024, and the company's common stock will open for trading on the nasdaq capital market on october 25, 2024 on a post-split basis, under the existing ticker symbol “amix” but with a new cusip number 05330t 205.
AMIX Ratings Summary
AMIX Quant Ranking